XML 115 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Statement of Consolidated Operations - USD ($)
shares in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]      
Sales (B) $ 14,192,000,000 $ 14,014,000,000 $ 12,960,000,000
Cost of goods sold (exclusive of expenses below) 11,227,000,000 11,397,000,000 10,221,000,000
Selling, general administrative, and other expenses 704,000,000 604,000,000 715,000,000
Research and development expenses 70,000,000 103,000,000 109,000,000
Provision for depreciation and amortization 536,000,000 576,000,000 551,000,000
Impairment of goodwill (A and N) 0 0 719,000,000
Restructuring and other charges (C) 620,000,000 9,000,000 165,000,000
Operating income 1,035,000,000 1,325,000,000 480,000,000
Interest expense (D) 338,000,000 378,000,000 496,000,000
Other expense (income), net (E) 122,000,000 79,000,000 (486,000,000)
Income before income taxes 575,000,000 868,000,000 470,000,000
Provision for income taxes (G) 105,000,000 226,000,000 544,000,000
Net income (loss) 470,000,000 642,000,000 (74,000,000)
Amounts Attributable to Arconic Common Shareholders (I):      
Net income (loss) $ 477,000,000 $ 651,000,000 $ (127,000,000)
Earnings (loss) per share - basic (in usd per share) $ 1.05 $ 1.33 $ (0.28)
Earnings (loss) per share - diluted (in usd per share) $ 1.03 $ 1.30  
Average Shares Outstanding (I):      
Average shares outstanding - basic (in shares) 446 483 451
Average shares outstanding - diluted (in shares) 463 503 451